Startups
Focused on oncology, we are committed to continuously innovating and developing new breakthrough cancer drugs, aiding cancer patients to gain an upper hand in the ceaseless fight against cancers.
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 24, 2025 | Global Launch Event for iza-bren Phase III Nasopharyngeal Carcinoma Research Results Successfully Held, Streamed on ESMO Official Website | SHANGHAI, Oct. 24, 2025 /PRNewswire/ -- At 15:00 Beijing Time (09:00 am Berlin Time) on October 20, the "Global Launch Event for Iza-bren (EGFR×HER3 Bispecific ADC) Nasopharyngeal Carcinoma BL-B01D1-303 Research Results" was held ... |
| SystImmune | “SystImmune, Inc.” |
Reviews 0
FAQ about SystImmune
What has the press written about SystImmune?
Parsers VC has collected 3 articles mentioning SystImmune, among them “Global Launch Event for iza-bren Phase III Nasopharyngeal Carcinoma Research Results Successfully Held, Streamed on ESMO Official Website” (Oct 24, 2025) and “SystImmune”.
Is SystImmune still active?
Yes, SystImmune is active; its latest activity on Parsers VC dates from Sep 28, 2026.